Literature DB >> 21698755

Metabolic pathways and intracellular trafficking of gangliosides.

Jose Luis Daniotti1, Ramiro Iglesias-Bartolomé.   

Abstract

Gangliosides constitute a large and heterogeneous family of acidic glycosphingolipids that contain one or more sialic acid residues and are expressed in nearly all vertebrate cells. Their de novo synthesis starts at the endoplasmic reticulum and is continued by a combination of glycosyltransferase activities at the Golgi complex, followed by vesicular delivery to the plasma membrane. At the cell surface, gangliosides participate in a variety of physiological as well as pathological processes. The cloning of genes for most of the glycosyltransferases responsible for ganglioside biosynthesis has produced a better understanding of the cellular and molecular basis of the ganglioside metabolism. In addition, the ability to delete groups of glycosphingolipid structures in mice has been enormously important in determining their physiological roles. Recently, a number of enzymes for ganglioside anabolism and catabolism have been shown to be associated with the plasma membrane, which might contribute to modulate local glycolipid composition, and consequently, the cell function.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21698755     DOI: 10.1002/iub.477

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  21 in total

1.  Trans-activity of plasma membrane-associated ganglioside sialyltransferase in mammalian cells.

Authors:  Aldo A Vilcaes; Vanina Torres Demichelis; Jose L Daniotti
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

2.  Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

Authors:  Roger Sandhoff; Konrad Sandhoff
Journal:  Adv Neurobiol       Date:  2023

Review 3.  Protein Toxins That Utilize Gangliosides as Host Receptors.

Authors:  Madison Zuverink; Joseph T Barbieri
Journal:  Prog Mol Biol Transl Sci       Date:  2018-03-17       Impact factor: 3.622

4.  Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials.

Authors:  Leonardo Nimrichter; Marcio L Rodrigues
Journal:  Front Microbiol       Date:  2011-10-20       Impact factor: 5.640

Review 5.  Defensins: antifungal lessons from eukaryotes.

Authors:  Patrícia M Silva; Sónia Gonçalves; Nuno C Santos
Journal:  Front Microbiol       Date:  2014-03-20       Impact factor: 5.640

Review 6.  Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approaches.

Authors:  Jose L Daniotti; Aldo A Vilcaes; Vanina Torres Demichelis; Fernando M Ruggiero; Macarena Rodriguez-Walker
Journal:  Front Oncol       Date:  2013-12-19       Impact factor: 6.244

Review 7.  Ganglioside biochemistry.

Authors:  Thomas Kolter
Journal:  ISRN Biochem       Date:  2012-12-19

Review 8.  Insights on the trafficking and retro-translocation of glycosphingolipid-binding bacterial toxins.

Authors:  Jin A Cho; Daniel J-F Chinnapen; Emil Aamar; Yvonne M te Welscher; Wayne I Lencer; Ramiro Massol
Journal:  Front Cell Infect Microbiol       Date:  2012-04-11       Impact factor: 5.293

9.  Targeted delivery of immunotoxin by antibody to ganglioside GD3: a novel drug delivery route for tumor cells.

Authors:  Vanina Torres Demichelis; Aldo A Vilcaes; Ramiro Iglesias-Bartolomé; Fernando M Ruggiero; Jose L Daniotti
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis.

Authors:  Gaurav V Harlalka; Anna Lehman; Barry Chioza; Emma L Baple; Reza Maroofian; Harold Cross; Ajith Sreekantan-Nair; David A Priestman; Saeed Al-Turki; Meriel E McEntagart; Christos Proukakis; Louise Royle; Radoslaw P Kozak; Laila Bastaki; Michael Patton; Karin Wagner; Roselyn Coblentz; Joy Price; Michelle Mezei; Kamilla Schlade-Bartusiak; Frances M Platt; Matthew E Hurles; Andrew H Crosby
Journal:  Brain       Date:  2013-10-07       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.